CHARLENE BUI: Open Payments
NPI 1144258484 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 73 payments from 19 companies in 2025. Trend: 2023 $1,260 · 2024 $1,436 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $158 |
| Novo Nordisk Inc | 15 | $151 |
| Hologic Sales and Service, LLC | 3 | $136 |
| Vanda Pharmaceuticals Inc. | 2 | $96 |
| Medtronic, Inc. | 3 | $89 |
| Amgen Inc. | 3 | $44 |
| Abbott Laboratories | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
Products named: XIFAXAN, APTIMA, Ozempic, FANAPT, INTELLIS ADAPTIVESTIM, VRAYLAR, QULIPTA, UBRELVY.
Industry payments across KS — which companies pay providers there.
